Document is current
Any future updates will be listed below
-
Authors
Karakaslar, E. Onur https://orcid.org/0000-0002-9182-910X
Argiro, Eva M. https://orcid.org/0009-0006-7006-2751
Struckman, Nadine E.
Shirali HZ, Ramin
Severens, Jeppe F. https://orcid.org/0000-0002-5524-0453
Honders, M. Willy
Kloet, Susan L.
Veelken, Hendrik https://orcid.org/0000-0002-9108-3125
Reinders, Marcel JT https://orcid.org/0000-0002-1148-1562
Griffioen, Marieke https://orcid.org/0000-0002-3001-4441
van den Akker, Erik B. https://orcid.org/0000-0002-7693-0728
-
Funding
Funding for this research was provided by:
KWF Kankerbestrijding (15152)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (09150161810095)
- License Information
-
More Information
Article History
Received: 29 January 2025
Revised: 22 July 2025
Accepted: 12 August 2025
First Online: 15 September 2025
Competing interests
: The authors declare no competing interests.
: All methods were performed in accordance with the relevant guidelines and regulations, including the Declaration of Helsinki. Approval to use NPM1-mutated AML patient samples for this research was obtained from the Leiden University Medical Center (LUMC) Institutional Review Board (protocol no. RP24.056). Written informed consent to participate was obtained from all participants prior to sample collection.
